TUCHMAN ALAN J 4
4 · Synaptogenix, Inc. · Filed Nov 17, 2022
Insider Transaction Report
Form 4
TUCHMAN ALAN J
DirectorChief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-11-15+112,000→ 112,000 totalExercise: $6.07Exp: 2032-11-15→ Common Stock, par value $0.0001 per share (112,000 underlying)
Footnotes (1)
- [F1]These options vested 50% on November 15, 2022 (the "Issuance Date") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer.